Verastem (VSTM) Common Equity (2011 - 2026)
Verastem's Common Equity came in at $49.99 million for Q2 2026, up 38.6% from $36.06 million a year earlier but down 38.9% from the prior quarter.
Powered by 
Analysis
Verastem (VSTM) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Verastem's Common Equity was $57.2 million.
- Common Equity carries a five-year compound annual growth rate of -13.1% (FY2020 to FY2025).
- Going back by year, Common Equity was -$28.89 million in FY2024, $57.37 million in FY2023 (+21.1%), $47.39 million in FY2022 (-45.9%) and $87.56 million in FY2021 (-24.0%).
- The five-year range for quarterly Common Equity is -$32.43 million (Q1 2025) to $101.59 million (Q2 2023).
- The fastest year-over-year change in Common Equity over five years came in Q2 2025 (growth of 91.3%), and the weakest in Q3 2024 (a decline of 86.7%).
- Business Quant data shows VSTM's Common Equity at $81.78 million (Q1 2026), $57.2 million (Q4 2025) and -$15.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Verastem | 703.05 Mn | 59.67 Mn | 36.32 Mn | 49.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.99 Mn |
| Mar 31, 2026 | 81.78 Mn |
| Dec 31, 2025 | 57.20 Mn |
| Sep 30, 2025 | -15.53 Mn |
| Jun 30, 2025 | 36.06 Mn |
| Mar 31, 2025 | -32.43 Mn |
| Dec 31, 2024 | -28.89 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 18.85 Mn |
| Mar 31, 2024 | 25.06 Mn |
| Dec 31, 2023 | 57.37 Mn |
| Sep 30, 2023 | 83.18 Mn |
| Jun 30, 2023 | 101.59 Mn |
| Mar 31, 2023 | 33.03 Mn |
| Dec 31, 2022 | 47.39 Mn |
| Sep 30, 2022 | 62.87 Mn |
| Jun 30, 2022 | 53.89 Mn |
| Mar 31, 2022 | 72.77 Mn |
| Dec 31, 2021 | 87.56 Mn |
| Sep 30, 2021 | 95.66 Mn |
API Access
Verastem Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();